Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
R-CHOP vs R-mini-CEOP in Elderly DLBCL Patients
NCT01148446Phase 3Completed
- Sponsor
- Fondazione Italiana Linfomi
- Start
- Jan 2003
- Primary completion
- Jan 2006
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of epirubicin, vinblastine in diffuse large B-cell lymphoma (DLBCL), sponsored by Fondazione Italiana Linfomi. Started Jan 2003; status: completed.
02
Drugs
epirubicinvinblastine
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT01148446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01148446.